Plan: OPEN | Option: Growth | V Srivatsa

31 Jul 20 | 12:00 AM

118.55 4.52 (3.97%)

  • Outperforms

    51.63%

    Return (1Y)

    beaten S&P BSE Healthcare TRI by 6.41%

  • Less Volatile

    1.44%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.50%

  • Consistent

    8/11

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Scheme Trivia

  • UTI-Pharma & Healthcare Fund (G) fund has been the 5th best in 5Y performance in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been given the 4th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • UTI-Pharma & Healthcare Fund (G) fund has been the 4th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year UTI-Healthcare Fund (G), has beaten by 6.41% (CAGR difference)

51.63%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of UTI-Healthcare Fund (G) is Lower than by -0.50%

1.44%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 8 out of Last 11 Months, i.e 72.73% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition